Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. - Wikidata - awgldk - TriplyDB

Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia.

Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia.

http://www.wikidata.org/entity/Q35913891

about

Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms Antifungal lock therapy Effect of alkylphospholipids on Candida albicans biofilm formation and maturation Flo11p adhesin required for meiotic differentiation in Saccharomyces cerevisiae minicolonies grown on plastic surfaces.Evaluation of Virulence Factors In vitro, Resistance to Osmotic Stress and Antifungal Susceptibility of Candida tropicalis Isolated from the Coastal Environment of Northeast Brazil.Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites.Epidemiology of Candida albicans and non-C.albicans of neonatal candidemia at a tertiary care hospital in western China The Evaluation of the virulence factors of clinical Candida isolates and the anti-biofilm activity of Elettaria cardamomum against multi-drug resistant Candida albicans.The effect of nanochitosans particles on Candida biofilm formation Antifungal susceptibility patterns, in vitro production of virulence factors, and evaluation of diagnostic modalities for the speciation of pathogenic Candida from blood stream infections and vulvovaginal candidiasis.Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories Candida "psilosis"--electromigration techniques and MALDI-TOF mass spectrometry for phenotypical discrimination.Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital.Canadian clinical practice guidelines for invasive candidiasis in adults.Catheter-related Candida bloodstream infection in intensive care unit patients: a subgroup analysis of the China-SCAN study Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates.PCR diagnosis of invasive candidiasis: systematic review and meta-analysis.MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond.Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation.Candida parapsilosis, an emerging fungal pathogen Epidemiology and treatment approaches in management of invasive fungal infections Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.Novel strategies to fight Candida species infection.Role of SFP1 in the Regulation of Candida albicans Biofilm Formation.Fungal biofilm resistance.A Novel Small Molecule Inhibitor of Candida albicans Biofilm Formation, Filamentation and Virulence with Low Potential for the Development of Resistance.Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014.Evaluation of capacity to detect ability to form biofilm in Candida parapsilosis sensu stricto strains by MALDI-TOF MS.The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study.Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors Candiduria in Catheter Associated Urinary Tract Infection with Special Reference to Biofilm Production.Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland, 2012-2013.Mortality in patients with early- or late-onset candidaemia The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins A case of Candida orthopsilosis associated septic arthritis in a patient with Systemic Lupus Erythematosus (SLE)A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients.

P2860

Q21194915-207F2076-2CC8-4472-ABCD-1F45783EA9DF Q26861656-CEE42F43-7329-4FA6-B2E1-3E423B5C2097 Q27025682-575B4858-C2FF-44BE-AA97-7E8E01B459FB Q28275463-49141F3D-11E2-4A5D-8849-504C8FC3F9A3 Q30499743-37CA160A-E5A3-4A10-84D5-9E270544ADCD Q30828568-4267CD46-AED7-4C87-84AA-4D7085BF10F1 Q33643814-C755AAEE-B591-4796-BF13-1FC5CA60B16C Q33644932-7BC3E6C3-892E-40E7-92A4-5521AEC75980 Q33851327-EC21E894-090B-4215-BF87-DB09B69D2813 Q33851342-3E392FB2-D96B-4224-8CE7-835B36C295DA Q33993054-DB1868EE-9628-4EAE-B6A7-802A8ECA2042 Q34058071-BB1BFD58-3E4B-498D-A44B-B3B41FCE76AA Q34076344-6F69528A-AA15-45B9-BAD6-D65F89B6C00C Q34187335-069E0B4D-53B9-4FA4-9060-D85CC8A94644 Q34221581-C9B41FC7-9405-4C23-B309-18BC579EFB43 Q34237335-5A883CBA-A477-42CF-B620-7622BDEFF53E Q34528210-5D0FBF9F-0B1A-420A-941D-06939CB4DAA0 Q34578357-00FB3795-04D8-4EF1-BFDE-CE9C7044ED83 Q34596714-2E67CE44-407F-4389-8836-239C3E9E98DD Q34662276-54767F1E-A891-4878-B8D0-15622792E4DA Q34676573-F3D6F45D-821E-4D9E-A974-E2E98313D44E Q34852747-AC04E11C-9FFE-435A-B170-7BE400D03BA8 Q35089772-D4AD3160-75BE-479A-A200-3C29422C28F4 Q35201457-F5C80711-AADB-481D-995F-FCDE28D2D405 Q35406737-17C3F40F-F508-4DBD-8773-05ECDF6914DA Q35667552-58C95507-9F55-44C6-A2BF-EC7D5312C326 Q35821475-14E7D6E7-ADCA-4E32-ADF9-4612F1B6324A Q35874892-250697B6-744A-450F-86D0-39BB54B9D0BD Q35908296-ADA80859-18BD-4B8C-A81D-77FE1A9260E9 Q35937325-21704920-EF87-417C-A14D-B06C58C337AF Q35986607-A96770B3-B881-4BEA-98CA-BE2DCC5BFD5C Q36010587-E319DDEC-EB1D-4AD5-8C96-D8340F2AA813 Q36177985-6176411F-4C46-4C9A-9F0E-15EA134EDAF9 Q36221893-BDE7512F-2230-4333-8E23-F6A1D3ACBF6E Q36401437-4651F048-36BC-452F-AC16-B56257CBA49A Q36486984-F6802D02-6B6D-4B45-9C3C-D05E461A5023 Q36675138-4A4269DD-039F-4E3C-BA80-998612FF1620 Q36974352-E4AF9DAB-E89E-4500-9CF4-DEE7D6840145 Q37009812-6369C1F2-2373-4F5F-B45B-4070DB65F1C0 Q37012419-FEE6A636-4C55-4316-9A37-59C08FDCB409

P2860

Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia.

http://www.wikidata.org/entity/Q35913891

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Biofilm production by Candida ...... for patients with candidemia.

@ast

Biofilm production by Candida ...... for patients with candidemia.

@en

type

label

Biofilm production by Candida ...... for patients with candidemia.

@ast

Biofilm production by Candida ...... for patients with candidemia.

@en

prefLabel

Biofilm production by Candida ...... for patients with candidemia.

@ast

Biofilm production by Candida ...... for patients with candidemia.

@en

P1433

Q35913891-4EE1571C-7746-4C55-8559-C05FC661470B

P1476

Q35913891-3F0A691F-B7EB-4FF3-B2CD-95B871CEACAD

P2093

Q35913891-2311C7AE-53D7-4577-B674-EE7BC699C89F

Q35913891-31D47667-AF52-4EAE-B966-017B4C70410B

Q35913891-3C4CFAE6-B0CE-4D76-A2FE-EA57DAF44014

Q35913891-495512CE-0FA3-46CE-B234-AA73B9781919

Q35913891-5E3DF04E-19D2-4342-8630-94ED516F63EB

Q35913891-890788DC-74A5-4E75-AEAA-191ED9473065

Q35913891-9B08E8FC-21CE-4A83-AAC7-6A8128715DDA

P2860

Q35913891-04AA0144-CE49-4377-88F4-AC37AABD07BA

Q35913891-102340E8-9BEF-4ABB-AAAD-A1190FD00FD4

Q35913891-15DFA859-E124-4C77-9919-3A8E49D6F6CE

Q35913891-19DAA4AB-487D-4FF8-8C58-01797C11B71C

Q35913891-19FE5A83-F65F-44C5-90A2-2F43664A57FB

Q35913891-1ACF624D-A72A-42D1-B322-0344CF4723F9

Q35913891-1DCCE0F1-F629-481E-93D5-42672E0F1ECF

Q35913891-255EFFC5-BC7F-463C-A35B-D3E7B473823E

Q35913891-279BE5BB-7E98-46CD-B9BE-456C988AF4B7

Q35913891-2EA83ADC-AEBE-47D8-BD0B-68D169B77BFB

P304

Q35913891-FC38EECE-753B-4AF2-97F4-9B3D4CFC9AA2

P31

Q35913891-9CA1BF0B-C2CB-4126-BE8E-B18372E39C61

P356

Q35913891-96A5EE69-EE22-40C1-9BFD-39E5B7162363

P407

Q35913891-ED361D60-702F-47E4-B5F1-4067CF2302D8

P433

Q35913891-52EE215E-3E33-4E63-A49F-84F7894A2DD9

P478

Q35913891-9715DDA8-AF27-4A53-96D5-AE12C00CCDAF

P50

Q35913891-21CFD8AD-C83E-48F5-98D6-4F51D6E82B03

Q35913891-4431DD04-B24A-4416-9E26-4BE2611AC519

Q35913891-6C13C210-1BE4-484A-952E-DA9A6348F3E7

Q35913891-C30A3F6E-EFE0-4914-9FB6-2DDA5DD8E6CF

Q35913891-E15F4E67-372F-4DC0-9139-FA896CB563FA

P577

Q35913891-8744EC62-1558-4748-8D21-84C65C36AD2F

P698

Q35913891-1BA4CB82-B9FD-4A69-84E3-697C8A835F94

P921

Q35913891-3EA4E3DA-7BF5-46BA-AEF1-42CF5575D09A

P932

Q35913891-8A250512-329D-400A-B3C5-AFD02C334B22

P356

P1433

Journal of Clinical Microbiology

P1476

Biofilm production by Candida ...... for patients with candidemia.

@en

P2093

Barbara Fiori

http://www.w3.org/2001/XMLSchema#string

Giovanni Fadda

http://www.w3.org/2001/XMLSchema#string

Marianna Rossi

http://www.w3.org/2001/XMLSchema#string

Marilena La Sorda

http://www.w3.org/2001/XMLSchema#string

Mario Tumbarello

http://www.w3.org/2001/XMLSchema#string

Rosaria Porta

http://www.w3.org/2001/XMLSchema#string

Teresa Spanu

http://www.w3.org/2001/XMLSchema#string

P2860

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

Epidemiology of invasive candidiasis: a persistent public health problem

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

Candida biofilms: an update.

Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces.

Quantitative variation of biofilms among strains in natural populations of Candida albicans.

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.

Candida biofilms.

P304

1843-1850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00131-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Sanguinetti

Brunella Posteraro

Enrico Maria Trecarichi

Katleen de Gaetano Donati

P577

2007-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17460052

http://www.w3.org/2001/XMLSchema#string

P921

P932

1933062

http://www.w3.org/2001/XMLSchema#string